Liraglutide Injection: A New Treatment Option for Overweight

Liraglutide should not be used in patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis Liraglutide is not a substitute for

As a part of a supply agreement with Novo Nordisk New Zealand Limited, liraglutide will be funded for people with type 2 diabetes who meet the

liraglutide Overview Evidence-based recommendations on liraglutide for managing overweight and obesity alongside a reduced-calorie diet and

liraglutide Weight loss of 5% or greater occurred in % with liraglutide and % with liraglutide vs % with placebo (estimated